Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2633 followers
Created: 2023-10-13 20:35:34 UTC

Pharma/Biotech Highlights:

$CBIO: FDA accepts Catalyst Pharma's S-NDA, advancing FIRDAPSEĀ®.
$ARDX: Ardelyx presents XPHOZAH data at Kidney Week.
$THTX: Study reports findings on Trogarzo administration.
$LBTSF: Almirall's Lebrikizumab aids dermatitis patients.

![](https://pbs.twimg.com/media/F8WM18zWkAAdbC2.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1712930096711979428/c:line.svg)

**Related Topics**
[$lbtsf](/topic/$lbtsf)
[$thtx](/topic/$thtx)
[$ardx](/topic/$ardx)
[$cbio](/topic/$cbio)

[Post Link](https://x.com/OzmosiHealth/status/1712930096711979428)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

OzmosiHealth Avatar Ozmosi @OzmosiHealth on x 2633 followers Created: 2023-10-13 20:35:34 UTC

Pharma/Biotech Highlights:

$CBIO: FDA accepts Catalyst Pharma's S-NDA, advancing FIRDAPSEĀ®. $ARDX: Ardelyx presents XPHOZAH data at Kidney Week. $THTX: Study reports findings on Trogarzo administration. $LBTSF: Almirall's Lebrikizumab aids dermatitis patients.

XXXXX engagements

Engagements Line Chart

Related Topics $lbtsf $thtx $ardx $cbio

Post Link

post/tweet::1712930096711979428
/post/tweet::1712930096711979428